UNIVERSAL CLL1 CAR-T

Clinical trials for UNIVERSAL CLL1 CAR-T explained in plain language.

Never miss a new study

Get alerted when new UNIVERSAL CLL1 CAR-T trials appear

Sign up with your email to follow new studies for UNIVERSAL CLL1 CAR-T, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Universal 'Off-the-Shelf' cell therapy tested for Tough-to-Treat leukemia

Disease control Not yet recruiting

This early-stage study is testing a new type of cell therapy called 'universal' CLL1 CAR-T for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The therapy uses genetically modified immune cells designed to find and attack leuke…

Matched conditions: UNIVERSAL CLL1 CAR-T

Phase: PHASE1 • Sponsor: Mingfeng Zhao • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

UNIVERSAL CLL1 CAR-T

Get alerted when new UNIVERSAL CLL1 CAR-T trials appear

Universal 'Off-the-Shelf' cell therapy tested for Tough-to-Treat leukemia